Proteros and CHDI Foundation, Inc. establish discovery services collaboration to address Huntington’s disease
Proteros Biostructures GmbH (Proteros) announced that it has entered into a service agreement with CHDI Foundation, Inc. (CHDI), under which Proteros will provide structure-based drug discovery services to CHDI. Proteros will apply its integrated discovery platform including proprietary X-ray crystallography tools to help CHDI in its mission to develop therapeutics that slow the progression of Huntington’s disease (HD).
Cony D’Cruz Chief Business Officer and President Proteros US, Inc. stated, “CHDI has been at the forefront of using a best-in-class network to assist in developing therapies for HD. We welcome the opportunity for Proteros to contribute to this effort.”
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
CyBio Well vario | Pipetting systems | Analytik Jena
The virulence of the Toxoplasma parasite identified
Phoenix Black | Muffle furnaces | CEM
WITec Paper Award 2025 winners announced - This year’s prizes reward scientists for their excellent work in material analysis, battery research and medical science
QX600 Droplet Digital PCR System | Droplet Digital PCR systems | Bio-Rad Laboratories
Purdue biodefense technology project awarded $1.3 million NIH seed grant
Drug discovery within the patient - Genetic analysis of bacteria from humans and animals paves the way for new active ingredients
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Offer price increased
Analytik Jena Opens Swiss Branch Office at the Endress+Hauser Headquarters
Adam Chong named new CEO of Rigaku Asia Pacific
Microscopy Today Innovation Award for novel X-ray lenses - High numerical aperture and sharp focus enable record resolution microscopy